VERACYTE, INC. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
VERACYTE, INC. (VCYT) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2026-02-26
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2015-12-31 was $0.00.
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2015-09-30 was $0.00.
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2015-06-30 was $0.00.
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2015-03-31 was $0.00.
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2025 was $0.00.
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2024 was $0.00.
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2023 was $0.00.
- VERACYTE, INC. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2022 was $0.00.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 derived: sum of 3 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $0.00 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-15 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |